Positive results from the T2NOW Phase III trial have demonstrated significant reduction in A1C, a marker of average blood sugar, for patients treated with Forxi 4 October 2023
Chicago, USA-based Meitheal Pharmaceuticals has announced an exclusive licensing agreement with Tonghua Dongbao Pharmaceutical to commercialize three insulin bi 22 September 2023
It may feel like groundhog day for the beleaguered backers of a novel drug-device product developed by biotech unicorn Intarcia Therapeutics. 22 September 2023
Research from a medical testing company, London Medical Laboratory, finds that there is a “critical medication shortage” facing many diabetics in the UK. 21 September 2023
Swiss drugmaker Novartis has launched legal action against the US Government, after authorities revealed the first drugs to be subject to pricing regulations ma 7 September 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.